Filing Details
- Accession Number:
- 0001437749-20-024177
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-18 18:02:33
- Reporting Period:
- 2020-11-16
- Accepted Time:
- 2020-11-18 18:02:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
787253 | Natural Alternatives International Inc | NAII | Medicinal Chemicals & Botanical Products (2833) | 841007839 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1115556 | A Mark Ledoux | 1535 Faraday Avenue Carlsbad CA 92008 | Ceo/Chairman | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-11-16 | 11,006 | $10.35 | 55,887 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 176,500 | Indirect | By Self as Trustee for the LeDoux Family Trust U/D/T December 21, 1992 |
Common Stock | 530,000 | Indirect | By LeDoux Family Limited Partnership |
Common Stock | 69,416 | Indirect | By IRA |
Common Stock | 7,200 | Indirect | By Self as Custodian for Marcelle Jeannette LeDoux |
Common Stock | 800 | Indirect | By Self as Custodian for Jean-Marc Emile LeDoux |
Common Stock | 4,000 | Indirect | By Self as Custodian for Aimee LeDoux |
Footnotes
- Represents the Officer and Director's net exercise of two Stock Options for a total of 40,000 shares and the Company's concurrent purchase of the remaining shares underlying the Option pursuant to the Company's Stock Repurchase Program.
- The shares were valued for determination of the exercise consideration and for the Company's purchase of the remaining shares at the closing price of the shares on Nasdaq on the trading day before the date of exercise.